Allostery Investments’s 89bio ETNB Stock Holding History

Allostery Investments’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,000	Closed	-$182K	–	27
2025 Q1	$182K	Buy	+25,000	New	+$219K	0.26%	34

Other funds holding ETNB

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Allostery Investments's ETNB Position: Q2 2025 in Review

Allostery Investments sold out of 89bio (ETNB) in Q2 2025, closing a stake of 25,000 shares — an estimated $182K sold.

Allostery Investments first reported a position in ETNB in Q1 2025 and held it in 1 quarter. The position peaked at $182K in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

Allostery Investments reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
Allostery Investments sold 25,000 89bio shares in Q2 2025, an estimated $182K.
Allostery Investments first reported a position in 89bio in Q1 2025 and held it in 1 quarter.
Allostery Investments's 89bio position peaked at $182K in Q1 2025.
184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Allostery Investments's 13F filing for Q2 2025, filed 14 Aug 2025.